Bayesian Optimal Designs for Phase I Clinical Trials (Q3079157)

From MaRDI portal
Revision as of 20:24, 3 July 2024 by ReferenceBot (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Bayesian Optimal Designs for Phase I Clinical Trials
scientific article

    Statements

    title
    Bayesian Optimal Designs for Phase I Clinical Trials (English)
    0 references
    author
    Linda M. Haines
    0 references
    Inna Perevozskaya
    0 references
    William F. Rosenberger
    0 references
    published in
    Biometrics
    0 references
    publication date
    1 March 2011
    0 references
    zbMATH Keywords
    constrained optimal design
    0 references
    maximum tolerated dose
    0 references
    sequential design
    0 references

    Identifiers

    Mathematics Subject Classification ID
    62P10
    0 references
    62F15
    0 references
    62K05
    0 references
    62L05
    0 references
    92C50
    0 references
    zbMATH DE Number
    5859256
    0 references
    Wikidata QID
    Q79257869
    0 references
    OpenAlex ID
    W1972194651
    0 references
     
    Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Item:Q3079157&oldid=35216420"
    Powered by MediaWiki